Alternatives to BiomX

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing novel diagnostics to predict patient response to immunotherapy.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Microbiome technology platform for developing novel therapeutics.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Harnessing genetic data for digital insights in rare and germline disorders.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Develops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.

Global leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.

Develops an endovascular solution for vasospasm treatment in aneurysmal subarachnoid hemorrhage.

Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases.

Bioz is an AI search engine for life science experimentation, helping scientists find validated and cost-effective products.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

AI-powered diagnostic imaging for early detection of diabetic retinopathy.

Transforming healthcare by turning scientific fiction into scientific facts.

A global oncology company developing and commercializing innovative cancer treatments.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing engineered biologics to harness the immune system for disease treatment.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Medical device company developing advanced sensor technology for oncology treatment.

Developing advanced bio-integrated devices for enhanced medical diagnostics and therapeutics.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Biomedical platform with intelligent search for medical citations and clinical trial recruitment.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

AI-powered care coordination platform for faster diagnosis and treatment of critical conditions.

Biotechnology company developing novel immunotherapies for cancer.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.

Immunotherapy company targeting oncology and autoimmune diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Clinical-stage immunotherapy company developing novel treatments for cancer.